Common mutation is culprit in acute leukemia relapse

Stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse. The research could translate into improved patient care strategies for this particular blood cancer, which typically affects children but is more deadly in adults.